Premarket assessment of molecular alterations in drug targets: a case study of 2020 drug approvals

Pharmacogenomics, Ahead of Print.

Source: Future Medicine: Pharmacogenomics - April 20, 2022 Category: Genetics & Stem Cells Authors: Oluseyi Adeniyi Mary Hwang Jielin Sun Robert N Schuck Source Type: research